Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Cash & Equivalents (2016 - 2025)

HUTCHMED (China) has reported Cash & Equivalents over the past 12 years, most recently at $57.3 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 62.77% to $57.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $57.3 million through Dec 2025, down 62.77% year-over-year, with the annual reading at $57.3 million for FY2025, 62.77% down from the prior year.
  • Cash & Equivalents was $57.3 million for Q4 2025 at HUTCHMED (China), down from $154.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $313.3 million in Q4 2022 and troughed at $57.3 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $154.0 million (2024), against an average of $182.6 million.
  • Year-over-year, Cash & Equivalents surged 199.44% in 2022 and then plummeted 62.77% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $104.6 million in 2021, then surged by 199.44% to $313.3 million in 2022, then dropped by 9.48% to $283.6 million in 2023, then crashed by 45.71% to $154.0 million in 2024, then plummeted by 62.77% to $57.3 million in 2025.
  • Per Business Quant, the three most recent readings for HCM's Cash & Equivalents are $57.3 million (Q4 2025), $154.0 million (Q4 2024), and $283.6 million (Q4 2023).